Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 152


Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.

Haring B, Wu C, Coker LH, Seth A, Snetselaar L, Manson JE, Rossouw JE, Wassertheil-Smoller S.

Am J Hypertens. 2015 Jul 1. pii: hpv081. [Epub ahead of print]


Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.

Chlebowski RT, Anderson GL, Prentice RL, Rossouw JE, Aragaki AK, Manson JE.

Climacteric. 2015 Jun;18(3):336-8. doi: 10.3109/13697137.2015.1038770.


Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Do R, Stitziel NO, Won HH, Jørgensen AB, Duga S, Angelica Merlini P, Kiezun A, Farrall M, Goel A, Zuk O, Guella I, Asselta R, Lange LA, Peloso GM, Auer PL; NHLBI Exome Sequencing Project, Girelli D, Martinelli N, Farlow DN, DePristo MA, Roberts R, Stewart AF, Saleheen D, Danesh J, Epstein SE, Sivapalaratnam S, Hovingh GK, Kastelein JJ, Samani NJ, Schunkert H, Erdmann J, Shah SH, Kraus WE, Davies R, Nikpay M, Johansen CT, Wang J, Hegele RA, Hechter E, Marz W, Kleber ME, Huang J, Johnson AD, Li M, Burke GL, Gross M, Liu Y, Assimes TL, Heiss G, Lange EM, Folsom AR, Taylor HA, Olivieri O, Hamsten A, Clarke R, Reilly DF, Yin W, Rivas MA, Donnelly P, Rossouw JE, Psaty BM, Herrington DM, Wilson JG, Rich SS, Bamshad MJ, Tracy RP, Cupples LA, Rader DJ, Reilly MP, Spertus JA, Cresci S, Hartiala J, Tang WH, Hazen SL, Allayee H, Reiner AP, Carlson CS, Kooperberg C, Jackson RD, Boerwinkle E, Lander ES, Schwartz SM, Siscovick DS, McPherson R, Tybjaerg-Hansen A, Abecasis GR, Watkins H, Nickerson DA, Ardissino D, Sunyaev SR, O'Donnell CJ, Altshuler D, Gabriel S, Kathiresan S.

Nature. 2015 Feb 5;518(7537):102-6. doi: 10.1038/nature13917. Epub 2014 Dec 10.


Reconciling the divergent findings from clinical trials and observational studies of menopausal hormone therapy for prevention of coronary heart disease.

Rossouw JE.

Semin Reprod Med. 2014 Nov;32(6):426-32. doi: 10.1055/s-0034-1384625. Epub 2014 Oct 16. Review.


The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials.

Shimbo D, Wang L, Lamonte MJ, Allison M, Wellenius GA, Bavry AA, Martin LW, Aragaki A, Newman JD, Swica Y, Rossouw JE, Manson JE, Wassertheil-Smoller S.

J Hypertens. 2014 Oct;32(10):2071-81; discussion 2081. doi: 10.1097/HJH.0000000000000287.


Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD.

Ann Intern Med. 2014 May 6;160(9):594-602. doi: 10.7326/M13-2348.


Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.

Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SA, Lavasani S, Rossouw JE, Prentice RL.

Breast Cancer Res. 2014 Mar 26;16(2):R30. doi: 10.1186/bcr3632.


Noakes misses the point.

Rossouw JE, Howard BV.

S Afr Med J. 2013 Dec;103(12):882. No abstract available.


Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.

Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM.

Genome Med. 2013 Dec 27;5(12):112. doi: 10.1186/gm517. eCollection 2013.


Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.

Howard BV, Rossouw JE.

Curr Opin Lipidol. 2013 Dec;24(6):493-9. doi: 10.1097/MOL.0000000000000022. Review.


Women's health initiative view of estrogen avoidance and all-cause mortality.

Prentice RL, Manson JE, Anderson GL, Lacroix AZ, Shumaker SA, Chlebowski RT, Howard BV, Stefanick ML, Jackson RD, Wactawski-Wende J, Rossouw JE.

Am J Public Health. 2013 Dec;103(12):e2. doi: 10.2105/AJPH.2013.301604. Epub 2013 Oct 17. No abstract available.


Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.

JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.


Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.

Shufelt CL, Merz CN, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS, Manson JE.

Menopause. 2014 Mar;21(3):260-6. doi: 10.1097/GME.0b013e31829a64f9.


Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane.

Prentice RL, Jackson RD, Pettinger M, Rossouw JE.

Osteoporos Int. 2014 Mar;25(3):1195. doi: 10.1007/s00198-013-2461-z. Epub 2013 Aug 3. No abstract available.


Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al.

Prentice RL, Jackson RD, Rossouw JE.

Osteoporos Int. 2013 Aug;24(8):2373-4. doi: 10.1007/s00198-013-2359-9. Epub 2013 Apr 6. No abstract available.


Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

Rossouw JE, Manson JE, Kaunitz AM, Anderson GL.

Obstet Gynecol. 2013 Jan;121(1):172-6. doi: http://10.1097/AOG.0b013e31827a08c8.


Study had insufficient power to investigate safety.

Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML.

BMJ. 2012 Dec 3;345:e8146; author reply e8164. doi: 10.1136/bmj.e8146. No abstract available.


Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.

Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE.

Osteoporos Int. 2013 Feb;24(2):567-80. doi: 10.1007/s00198-012-2224-2. Epub 2012 Dec 4.


Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.

Rossouw JE, Prentice RL, Manson JE, Aragaki AK, Hsia J, Martin LW, Kuller L, Johnson KC, Eaton C, Jackson R, Trevisan M, Allison M, Hoogeveen RC.

Circulation. 2012 Sep 25;126(13):1577-86. Epub 2012 Aug 29.


Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk.

Huang Y, Ballinger DG, Stokowski R, Beilharz E, Robinson JG, Liu S, Robinson RD, Henderson VW, Rossouw JE, Prentice RL.

Genome Med. 2012 Jul 13;4(7):57. doi: 10.1186/gm358. eCollection 2012.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk